These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22138275)

  • 1. Strengthening the case for stool DNA tests as first-line colorectal cancer screening: are we there yet?
    Lucas AL; Hwang C; Frucht H
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):214-5. PubMed ID: 22138275
    [No Abstract]   [Full Text] [Related]  

  • 2. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
    Berger BM; Ahlquist DA
    Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance improvements of stool-based screening tests.
    van Dam L; Kuipers EJ; van Leerdam ME
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in performance of fecal occult blood testing.
    Brenner H; Haug U; Hundt S
    Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of serum markers for the early detection of colorectal cancer.
    Wild N; Andres H; Rollinger W; Krause F; Dilba P; Tacke M; Karl J
    Clin Cancer Res; 2010 Dec; 16(24):6111-21. PubMed ID: 20798228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests.
    Kisiel JB; Ahlquist DA
    J Clin Gastroenterol; 2011 Apr; 45(4):301-8. PubMed ID: 20856138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool DNA testing: a new, noninvasive option for colorectal cancer screening.
    Ahlquist DA
    Clin Adv Hematol Oncol; 2015 Jul; 13(7):432-4. PubMed ID: 26353038
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
    Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
    Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal exfoliated cell in stool and its nuclear DNA quantitative analysis for diagnosis of colorectal cancer].
    Fan RY; Li SR; Wu ZT; Wu X; Chen ZM
    Ai Zheng; 2002 Jul; 21(7):776-80. PubMed ID: 12479106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.
    Loktionov A; O'Neill IK; Silvester KR; Cummings JH; Middleton SJ; Miller R
    Clin Cancer Res; 1998 Feb; 4(2):337-42. PubMed ID: 9516920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?
    Ferretti G; Bria E; Carlini P; Felici A; Giannarelli D; Cuppone F; Papaldo P; Nisticò C; Fabi A; Gelibter A; Terzoli E; Cognetti F
    Gut; 2005 Jun; 54(6):891. PubMed ID: 15888808
    [No Abstract]   [Full Text] [Related]  

  • 13. Fecal DNA analysis for colorectal cancer screening.
    Blue Cross Blue Shield Asssociation
    Technol Eval Cent Assess Program Exec Summ; 2014 Dec; 29(8):1-2. PubMed ID: 25577821
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal occult blood testing.
    Sanford KW; McPherson RA
    Clin Lab Med; 2009 Sep; 29(3):523-41. PubMed ID: 19840685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stool DNA test (Cologuard) for colorectal cancer screening.
    Med Lett Drugs Ther; 2014 Oct; 56(1453):100-1. PubMed ID: 25296259
    [No Abstract]   [Full Text] [Related]  

  • 16. A blood-based DNA test for colorectal cancer screening.
    Schmidt K; Diehl F
    Discov Med; 2007 Feb; 7(37):7-12. PubMed ID: 17343799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stool DNA and colorectal-cancer screening.
    Robertson DJ; Dominitz JA
    N Engl J Med; 2014 Apr; 370(14):1350-1. PubMed ID: 24645801
    [No Abstract]   [Full Text] [Related]  

  • 18. Colorectal cancer. Advances in stool DNA testing lead to improved colorectal cancer detection rates.
    Patman G
    Nat Rev Gastroenterol Hepatol; 2014 May; 11(5):269. PubMed ID: 24709816
    [No Abstract]   [Full Text] [Related]  

  • 19. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The imperative of equal funding for studies that evaluate any of the evidence-based, guideline-recommended colorectal cancer screening tests.
    Allison JE
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1269-71. PubMed ID: 19695347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.